Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ruffault

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patientsC Michelet, A Ruffault, V Sébille, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudineC Michelet, E Bellissant, A Ruffault, et al.
AIDS (London, England)|October 2, 2001
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide studyD Descamps, V Calvez, J Izopet, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2012
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypesS Reigadas, A G Marcelin, A Houssaïni, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitorsB Masquelier, E Race, C Tamalet, et al.
AIDS Research and Human Retroviruses|January 12, 2001
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatmentM Burgard, J Izopet, B Dumon, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2008
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavirB Masquelier, K L Assoumou, D Descamps, et al.
Antiviral Therapy|February 22, 2000
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over studyB Masquelier, D Descamps, I Carrière, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patientsC Michelet, A Ruffault, V Sébille, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudineC Michelet, E Bellissant, A Ruffault, et al.
AIDS (London, England)|October 2, 2001
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide studyD Descamps, V Calvez, J Izopet, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2012
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypesS Reigadas, A G Marcelin, A Houssaïni, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitorsB Masquelier, E Race, C Tamalet, et al.
AIDS Research and Human Retroviruses|January 12, 2001
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatmentM Burgard, J Izopet, B Dumon, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2008
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavirB Masquelier, K L Assoumou, D Descamps, et al.
Antiviral Therapy|February 22, 2000
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over studyB Masquelier, D Descamps, I Carrière, et al.
Pageof 4